Analystreport

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating.

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report